Natsar Pharmaceuticals, Inc.
CIK 2134002 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Natsar Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| May 8, 2026 | D | 0002134002-26-000001 |